1. Home
  2. PARK vs CLNN Comparison

PARK vs CLNN Comparison

Compare PARK & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PARK

Park Dental Partners Inc.

N/A

Current Price

$18.45

Market Cap

81.9M

Sector

Health Care

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$6.62

Market Cap

85.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PARK
CLNN
Founded
1972
2012
Country
United States
United States
Employees
1212
79
Industry
Misc Health and Biotechnology Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.9M
85.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PARK
CLNN
Price
$18.45
$6.62
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
14.4K
607.3K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.06
$17.64
Revenue Next Year
$6.17
$19,516.77
P/E Ratio
$6.47
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.29
$2.36
52 Week High
$21.60
$13.50

Technical Indicators

Market Signals
Indicator
PARK
CLNN
Relative Strength Index (RSI) 54.76 50.61
Support Level $16.66 $6.59
Resistance Level $19.14 $6.92
Average True Range (ATR) 0.98 0.69
MACD 0.04 -0.06
Stochastic Oscillator 61.41 41.42

Price Performance

Historical Comparison
PARK
CLNN

About PARK Park Dental Partners Inc.

Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: